Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

BACKGROUND: The first COVID-19 vaccine outside a clinical trial setting was administered on Dec 8, 2020. However, inadequate access to vaccines in low-income countries has limited the impact in these settings, reinforcing the need for global vaccine equity and coverage.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 To ensure global vaccine equity, vaccine targets were set by the COVID-19 Vaccines Global Access (COVAX) Facility and WHO.
• 2 However, due to vaccine shortfalls, these targets were not achieved by the end of 2021.
• 3 We aimed to quantify the global impact of the first year of COVID-19 vaccination programmes.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: